BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1913465)

  • 1. The significance of squamous differentiation in endometrial carcinoma. Data from a Gynecologic Oncology Group study.
    Zaino RJ; Kurman R; Herbold D; Gliedman J; Bundy BN; Voet R; Advani H
    Cancer; 1991 Nov; 68(10):2293-302. PubMed ID: 1913465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Squamous differentiation in carcinoma of the endometrium: a critical appraisal of adenoacanthoma and adenosquamous carcinoma.
    Zaino RJ; Kurman RJ
    Semin Diagn Pathol; 1988 May; 5(2):154-71. PubMed ID: 3041509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial adenocarcinoma with squamous cell differentiation.
    Abeler VM; Kjørstad KE
    Cancer; 1992 Jan; 69(2):488-95. PubMed ID: 1728379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidirectional differentiation of endometrial carcinoma with special reference to tumor aggressiveness evaluated by Ki-67 expression.
    Ikawa S; Sano T; Furumoto H; Aono T
    Gynecol Oncol; 1999 Mar; 72(3):323-30. PubMed ID: 10053102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of squamous differentiation in stage I endometrial adenocarcinoma.
    Demopoulos RI; Dubin N; Noumoff J; Blaustein A; Sommers GM
    Obstet Gynecol; 1986 Aug; 68(2):245-50. PubMed ID: 3737041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenocarcinoma, adenoacanthoma, and mixed adenosquamous carcinoma of the endometrium.
    Pekin T; Yildizhan B; Eren F; Pekin O; Yildizhan R
    Eur J Gynaecol Oncol; 2001; 22(2):151-3. PubMed ID: 11446483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New cytogenetic classification of precancerous lesions and carcinomas of the endometrium: possibilities and limits of immunohistochemical differentiation].
    Dallenbach-Hellweg G
    Verh Dtsch Ges Pathol; 1991; 75():357-62. PubMed ID: 1724841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic factors of endometrial carcinoma: a study of 98 cases].
    Yin LJ
    Zhonghua Fu Chan Ke Za Zhi; 1993 Mar; 28(3):150-2, 188. PubMed ID: 8354094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic evaluation of endometrial carcinoma by DNA content and histologic factors].
    Shimizu K
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Apr; 47(4):413-8. PubMed ID: 7730696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis and mitosis as prognostic factors in pathologically staged N1 nonsmall cell lung cancer.
    Komaki R; Fujii T; Perkins P; Ro JY; Allen PK; Mason KA; Mountain CF; Milas L
    Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):601-5. PubMed ID: 8948344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of the revised International Federation of Gynecology and Obstetrics histologic grading of endometrial adenocarcinoma using a defined nuclear grading system. A Gynecologic Oncology Group study.
    Zaino RJ; Kurman RJ; Diana KL; Morrow CP
    Cancer; 1995 Jan; 75(1):81-6. PubMed ID: 7804981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Federation of Gynecology and Obstetrics staging of endometrial cancer 1988.
    Mikuta JJ
    Cancer; 1993 Feb; 71(4 Suppl):1460-3. PubMed ID: 8431880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosquamous carcinoma of the endometrium. An entity with an inherent poor prognosis?
    Salazar OM; DePapp EW; Bonfiglio TA; Feldstein ML; Rubin P; Rudolph JH
    Cancer; 1977 Jul; 40(1):119-30. PubMed ID: 880545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
    Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
    Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial carcinomas--flow cytometric DNA content and S-phase values.
    Jacobsen M; Jakobsen A; Nedergaard L; Andersen JE; Nielsen K
    Pathol Res Pract; 1997; 193(4):283-90. PubMed ID: 9258954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pap smears in women with endometrial carcinoma.
    Gu M; Shi W; Barakat RR; Thaler HT; Saigo PE
    Acta Cytol; 2001; 45(4):555-60. PubMed ID: 11480718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study.
    Look KY; Brunetto VL; Clarke-Pearson DL; Averette HE; Major FJ; Alvarez RD; Homesley HD; Zaino RJ
    Gynecol Oncol; 1996 Dec; 63(3):304-11. PubMed ID: 8946863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
    Seki T; Tanabe H; Nagata C; Suzuki J; Suzuki K; Takano H; Isonishi S; Ochiai K; Takakura S; Okamoto A
    Jpn J Clin Oncol; 2017 Jan; 47(1):32-38. PubMed ID: 27677664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between clinical and surgical staging for endometrial cancer in Thailand.
    Buranawattanachoke S; Leelahakorn S; Tangjitgamol S; Manusirivithaya S; Khunnarong J
    Asian Pac J Cancer Prev; 2009; 10(4):685-90. PubMed ID: 19827895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.